Mosquera M Silena, Yuter Sara, Flake Alan W
Center for Fetal Research, Department of Surgery, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA.
Center for Fetal Research, Department of Surgery, Children's Hospital of Philadelphia Research Institute, Philadelphia, PA, USA.
Semin Fetal Neonatal Med. 2023 Oct;28(5):101485. doi: 10.1016/j.siny.2023.101485. Epub 2023 Nov 20.
The ex-utero intrapartum treatment (EXIT) procedure was originally developed to reverse tracheal occlusion in fetuses with severe congenital diaphragmatic hernia that underwent fetal tracheal occlusion. The EXIT procedure has since been applied to a wide range of indications, but the primary indication remains securing a patent airway and providing respiratory support in fetuses with anticipated difficult airways. The authors review perinatal management of the anticipated difficult airway and their single-institution's experience with the EXIT procedure.
子宫外产时处理（EXIT）程序最初是为了对接受胎儿气管阻塞治疗的严重先天性膈疝胎儿进行气管阻塞逆转而开发的。此后，EXIT程序已应用于广泛的适应症，但主要适应症仍然是确保预期气道困难的胎儿气道通畅并提供呼吸支持。作者回顾了预期困难气道的围产期管理以及他们单机构在EXIT程序方面的经验。
